Publications by authors named "Christel B Jensen"

Background: Rapid and accurate detection of viral respiratory infections is important for infection control measures. This study compares the analytical and clinical performance of the Xpert® Xpress CoV-2/Flu/RSV plus test ("Xpert", Cepheid) and the STANDARD™ M10 Flu/RSV/SARS-CoV-2 test ("M10", SD Biosensor). Both tests are quadruplex RT-PCR assays for rapid diagnosis of SARS-CoV-2, influenza A/B and RSV.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared the performance of fully automated antigen tests (AAT) to RT-PCR testing for SARS-CoV-2 during the pandemic.
  • The analysis involved a retrospective review of samples and a prospective clinical evaluation with a total of 405 individuals, assessing sensitivity and specificity of the tests.
  • Results showed that AATs had high specificity (97%-100%) but varied sensitivity (26%-88%), with mid-turbinate nasal swabs yielding better results than deep oropharyngeal swabs.
View Article and Find Full Text PDF

Background: The SARS-CoV-2 pandemic has resulted in massive testing by Rapid Antigen Tests (RAT) without solid independent data regarding clinical performance being available. Thus, decision on purchase of a specific RAT may rely on manufacturer-provided data and limited peer-reviewed data.

Methods: This study consists of two parts.

View Article and Find Full Text PDF

Introduction SARS-CoV-2 outbreaks at care homes are associated with a high morbidity and mortality. We aimed to study the molecular epidemiology of a major care home outbreak in Denmark. Methods After a staff member had been tested positive on 16 November 2020, a bundle approach programme was initiated including frequent surveillance screenings of residents and staff, isolation and cohorting procedures.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify the main strains of Bordetella pertussis in Greece between 2010-2015 by analyzing samples from hospitalized infants and children with suspected pertussis infection.
  • A total of 300 samples were confirmed positive for B. pertussis, with MLVA analysis revealing that the dominant genotype was MLVA type 27, which was found in 55 of the samples, and all tested samples showed the ptxP3 genotype.
  • Despite a 90% vaccine coverage in the general Greek population, the study highlighted low vaccination rates among Roma and immigrant groups, who comprised a significant portion of the study population.
View Article and Find Full Text PDF

The natural product argiotoxin-636 (ArgTX-636) found in the venom of the Argiope lobata spider is a potent open-channel blocker of ionotropic glutamate (iGlu) receptors, and recently, two analogues, ArgTX-75 and ArgTX-48, were identified with increased potency and selectivity for iGlu receptor subtypes. Here, we have exploited these analogues as templates in the development of fluorescent iGlu receptor ligands to be employed as unique tools for dynamic studies. Eighteen fluorescent analogues were designed and synthesized, and subsequently pharmacologically evaluated at three iGlu receptor subtypes, which resulted in the discovery of highly potent fluorescent iGlu receptor antagonists with IC50 values as low as 11 nM.

View Article and Find Full Text PDF

Argiotoxin-636 (ArgTX-636), a natural product from the spider Argiope lobata, is a potent but nonselective open-channel blocker of ionotropic glutamate (iGlu) receptors. Here, three series of analogues were designed to exploit selectivity among iGlu receptors, taking advantage of a recently developed solid-phase synthetic methodology for the synthesis of ArgTX-636 and analogues. Initially, the importance of secondary amino groups in the polyamine chain was studied by the synthesis of systematically modified ArgTX-636 analogues, which were evaluated for pharmacological activity at NMDA and AMPA receptors.

View Article and Find Full Text PDF